| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
17.110 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
CEBPA |
CEBPA: CCAAT/enhancer-binding protein alpha |
17.110 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
C3 |
|
17.110 |
Evidence |
|
| NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
17.110 |
Evidence |
|
| F3 |
F3: Tissue factor precursor |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
17.110 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
17.110 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
MPL |
MPL, TPOR: Thrombopoietin receptor precursor |
17.110 |
Evidence |
|
| ELA2 |
ELA2: Leukocyte elastase precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
17.110 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
MPL |
MPL, TPOR: Thrombopoietin receptor precursor |
17.110 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
IFNAR1 |
IFNAR1, IFNAR: Interferon-alpha/beta receptor alpha chain precursor |
17.110 |
Evidence |
|
| CFI |
CFI, IF: Complement factor I precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
17.110 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
PTPRJ |
PTPRJ, DEP1: Receptor-type tyrosine-protein phosphatase eta precursor |
17.110 |
Evidence |
|
| LHB |
LHB: Lutropin subunit beta precursor |
CGB |
CGB, CGB3, CGB5, CGB7, CGB8: Choriogonadotropin subunit beta precursor |
17.110 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
17.110 |
Evidence |
|
| WASPIP |
IPI00552369 |
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
17.110 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
MPP6 |
MPP6, VAM1: MAGUK p55 subfamily member 6 |
17.110 |
Evidence |
|
| PLD2 |
PLD2: Phospholipase D2 |
NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
17.110 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
PRKAA1 |
IPI00011891 |
17.110 |
Evidence |
|
| PSMB7 |
PSMB7: Proteasome subunit beta type-7 precursor |
PSMB4 |
IPI00556607 |
17.110 |
Evidence |
|
| SUMO3 |
SUMO3, SMT3A, SMT3H1: Small ubiquitin-related modifier 3 precursor |
SUMO2 |
SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor |
17.110 |
Evidence |
|
| PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
17.110 |
Evidence |
|
| IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
PHKG1 |
PHKG1, PHKG: Phosphorylase b kinase gamma catalytic chain, skeletal muscle isofo |
17.110 |
Evidence |
|
| IQGAP1 |
IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
17.110 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
ELMO1 |
IPI00219532 |
17.110 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
17.110 |
Evidence |
|